Advertisement

Topics

Sandoz widens launch of EpiPen rival as shortage continues

07:32 EDT 10 Jul 2019 | BioPharmaDive

Manufacturing issues have kept EpiPen in shortage for more than a year, opening a window for Sandoz to build share for Adamis' Symjepi. 

Original Article: Sandoz widens launch of EpiPen rival as shortage continues

NEXT ARTICLE

More From BioPortfolio on "Sandoz widens launch of EpiPen rival as shortage continues"

Advertisement
Quick Search
Advertisement
Advertisement